Florent Puisset

Documents

Publications

Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia

Florent Puisset , Emmanuel Raffoux , Lionel Ades , Tony Huynh , Raphaël Itzykson et al.

Haematologica, 2025, 110 (7), pp.1649-1653. ⟨10.3324/haematol.2024.286062⟩

Article dans une revue hal-04920565v1

Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO)

Florence Ranchon , Florian Slimano , Isabelle Borget , Mathieu Boulin , Christophe Bardin et al.

Annales Pharmaceutiques Françaises, 2025, 83 (6), pp.1040-1052. ⟨10.1016/j.pharma.2025.07.005⟩

Article dans une revue hal-05470190v1

A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions

Pauline Claraz , Luc Fillaudeau , Chloé Jadoul , Thomas Storme , Coralie Guillemot et al.

European Journal of Pharmaceutics and Biopharmaceutics, 2025, 207, pp.114622. ⟨10.1016/j.ejpb.2024.114622⟩

Article dans une revue hal-04875081v1

Cartographie française des activités de pharmacie clinique réalisées auprès des patients âgés atteints de cancer : une enquête SFPO-SFPC

Chloé Herledan , Anne Toulemonde , Mathilde Sturmia , Anne-Laure Clairet , Aurélie Terrier-Lenglet et al.

Bulletin du Cancer, 2025, 112 (5), pp.495-504. ⟨10.1016/j.bulcan.2024.12.017⟩

Article dans une revue hal-05054527v1

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

Benoit Blanchet , Alexandre Xu-Vuilard , Anne Jouinot , Florent Puisset , David Combarel et al.

British Journal of Cancer, 2024, 130 (6), pp.961-969. ⟨10.1038/s41416-024-02585-y⟩

Article dans une revue hal-04821736v1

Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy

Louise Laloi , Natacha Chaumard Billotey , Pierre-Yves Dumas , Franciane Paul , Alban Villate et al.

Cancer Medicine, 2023, 12 (6), pp.7175-7181. ⟨10.1002/cam4.5459⟩

Article dans une revue hal-04972259v1

Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study

Florent Puisset , Félicien Le Louedec , Florence Dalenc , Lorène Verguet , Eleonora de Maio et al.

British Journal of Clinical Pharmacology, 2023, 89 (7), pp.2283-2294. ⟨10.1111/bcp.15702⟩

Article dans une revue hal-04972257v1

Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases

Xavier Boumaza , Margaux Lafaurie , Emmanuel Treiner , Ondine Walter , Gregory Pugnet et al.

International Immunopharmacology, 2023, 120, pp.110342. ⟨10.1016/j.intimp.2023.110342⟩

Article dans une revue hal-04972256v1

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer

Florent Puisset , Mourad Mseddi , Loïc Mourey , Damien Pouessel , Benoit Blanchet et al.

Cancers, 2023, 15 (1), pp.313. ⟨10.3390/cancers15010313⟩

Article dans une revue hal-04973562v1

Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines

Maud Maillard , Audrey Eche-Gass , Mony Ung , Aurélie Brice , Sabrina Marsili et al.

Cancer Chemotherapy and Pharmacology, 2021, 87 (4), pp.579-583. ⟨10.1007/s00280-021-04233-1⟩

Article dans une revue hal-04972262v1

Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr

Félicien Le Louedec , Florent Puisset , Fabienne Thomas , Étienne Chatelut , Mélanie White-Koning

CPT: Pharmacometrics and Systems Pharmacology, 2021, 10 (10), pp.1208-1220. ⟨10.1002/psp4.12689⟩

Article dans une revue hal-04821229v1

Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data

Félicien Le Louedec , Fanny Gallais , Fabienne Thomas , Mélanie White-Koning , Ben Allal et al.

Pharmaceuticals, 2021, 14 (2), pp.162. ⟨10.3390/ph14020162⟩

Article dans une revue inserm-04791320v1

Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr

Félicien Le Louedec , Florent Puisset , Fabienne Thomas , Étienne Chatelut , Mélanie White-Koning

CPT: Pharmacometrics and Systems Pharmacology, 2021, 10 (10), pp.1208-1220. ⟨10.1002/psp4.12689⟩

Article dans une revue hal-04972260v1

Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance

Melanie White-Koning , Marie Noëlle Paludetto , Félicien Le Louedec , Laurence Gladieff , Christine Chevreau et al.

Cancer Chemotherapy and Pharmacology, 2020, 85 (3), pp.585-592. ⟨10.1007/s00280-019-04020-z⟩

Article dans une revue hal-04973418v1

Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples

Marie-Noelle Paludetto , Jean-Luc Stigliani , Anne Robert , Vania Bernardes-Génisson , Etienne Chatelut et al.

Chemical Research in Toxicology, 2020, 33 (1), pp.181-190. ⟨10.1021/acs.chemrestox.9b00205⟩

Article dans une revue hal-02448694v1

Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples

Marie-Noëlle Paludetto , Jean-Luc Stigliani , Anne Robert , Vania Bernardes-Génisson , Etienne Chatelut et al.

Chemical Research in Toxicology, 2020, 33 (1), pp.181-190. ⟨10.1021/acs.chemrestox.9b00205⟩

Article dans une revue hal-04973511v1

Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma

Lucie Oberic , Faustine Delzor , Caroline Protin , Sophie Perriat , Camille Laurent et al.

Journal of Oncology Pharmacy Practice, 2020, 27 (7), pp.1730-1735. ⟨10.1177/1078155220968615⟩

Article dans une revue hal-04920640v1

Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination

Pauline Claraz , Isabelle Riff , Charlotte Vert , Elina Wolff , Sophie Perriat et al.

American Journal of Health-System Pharmacy, 2020, 77 (22), pp.1866-1873. ⟨10.1093/ajhp/zxaa357⟩

Article dans une revue hal-04920636v1

Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors

Camille Azam , Pauline Claraz , Christine Chevreau , Camille Vinson , Ewa Cottura et al.

European Journal of Clinical Pharmacology, 2020, 76 (4), pp.579-587. ⟨10.1007/s00228-020-02828-w⟩

Article dans une revue hal-04973416v1

Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS

Marie-Noëlle Paludetto , Florent Puisset , Félicien Le Louedec , Ben Allal , Thierry Lafont et al.

Journal of Pharmaceutical and Biomedical Analysis, 2018, 154, pp.373-383. ⟨10.1016/j.jpba.2018.03.013⟩

Article dans une revue istex hal-04970346v1

Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites

Marie-Noëlle Paludetto , Christian Bijani , Florent Puisset , Vania Bernardes-Génisson , Cécile Arellano et al.

Journal of Medicinal Chemistry, 2018, 61 (17), pp.7849-7860. ⟨10.1021/acs.jmedchem.8b00812⟩

Article dans une revue hal-04973547v1

Metalloporphyrin-catalyzed oxidation of sunitinib and pazopanib, two anticancer tyrosine kinase inhibitors: Evidence for new potentially toxic metabolites

Marie-Noëlle Paludetto , Christian Bijani , Florent Puisset , Vania Bernardes-Génisson , C. Arellano et al.

Journal of Medicinal Chemistry, 2018, 61 (17), pp.7849-7860. ⟨10.1021/acs.jmedchem.8b00812⟩

Article dans une revue hal-01952871v1

Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit

Florent Puisset , Laurence Bigay-Game , Marie Noëlle Paludetto , Audrey Martel , Sophie Perriat et al.

Supportive Care in Cancer, 2018, 27 (5), pp.1679-1686. ⟨10.1007/s00520-018-4415-7⟩

Article dans une revue hal-04970347v1

Standardization of chemotherapy and individual dosing of platinum compounds.

Florent Puisset , Antonin Schmitt , Etienne Chatelut

Anticancer Research, 2014, 34 (1), pp.465-70

Article dans une revue hal-04970342v1

The Scientific Basis of Body Surface Area–Based Dosing

E Chatelut , F Puisset

Clinical Pharmacology and Therapeutics, 2014, 95 (4), pp.359-361. ⟨10.1038/clpt.2014.7⟩

Article dans une revue istex hal-04970344v1

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease

Florent Puisset , Mélanie White-Koning , Nassim Kamar , Antoine Huart , Frédérique Haberer et al.

British Journal of Clinical Pharmacology, 2013, 76 (5), pp.734-740. ⟨10.1111/bcp.12098⟩

Article dans une revue hal-04970340v1

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents

E Chatelut , M White-Koning , R Hj Mathijssen , F Puisset , S Baker et al.

British Journal of Cancer, 2012, 107 (7), pp.1100-1106. ⟨10.1038/bjc.2012.357⟩

Article dans une revue hal-04970339v1

Clinical pharmacodynamic factors in docetaxel toxicity

F Puisset , J Alexandre , J-M Treluyer , V Raoul , H Roché et al.

British Journal of Cancer, 2007, 97 (3), pp.290-296. ⟨10.1038/sj.bjc.6603872⟩

Article dans une revue hal-04970337v1

Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect

F. Puisset , E. Chatelut , A. Sparreboom , J.-P. Delord , D. Berchery et al.

Cancer Chemotherapy and Pharmacology, 2006, 60 (2), pp.305-308. ⟨10.1007/s00280-006-0385-4⟩

Article dans une revue istex hal-04970336v1

Dexamethasone as a probe for vinorelbine clearance

Florent Puisset , Florence Dalenc , Etienne Chatelut , Thierry Cresteil , Isabelle Lochon et al.

British Journal of Clinical Pharmacology, 2005, 60 (1), pp.45-53. ⟨10.1111/j.1365-2125.2005.02384.x⟩

Article dans une revue hal-04970324v1

Dexamethasone as a probe for docetaxel clearance

Florent Puisset , Etienne Chatelut , Florence Dalenc , Florent Busi , Thierry Cresteil et al.

Cancer Chemotherapy and Pharmacology, 2004, 54 (3), pp.265-72. ⟨10.1007/s00280-004-0823-0⟩

Article dans une revue istex hal-04970323v1

Pharmacocinétique

F Puisset

Pharmacie Clinique pratique en cancérologie., 2ème édition, elsevier, 2020, 9782294763755

Chapitre d'ouvrage hal-04973604v1

Resistance of Melanoma to Immune Checkpoint Inhibitors is Overcome by Targeting the Sphingosine Kinase 1

Céline Colacios , Caroline Imbert , Anne Montfort , Marine Fraisse , Elie Marcheteau et al.

Canceropole GSO, Canceropole GSO, Nov 2019, Arcachon, France

Communication dans un congrès hal-04993281v1

Chargement...